Becker's Healthcare September 30, 2024
Rylee Wilson

GLP-1’s are the No. 1 question on employers’ minds when it comes to healthcare benefits, Kasey Raetz, PharmD, told Becker’s. Cigna’s EncircleRx program provides some answers.

Dr. Raetz is vice president of product, pharma contracting and strategy at Evernorth, the Cigna Group’s health services business.

Cigna launched EncircleRx, a program to help employers control the cost of GLP-1 drugs for weight loss, in March. The program now covers over 5 million people, Dr. Raetz told Becker’s.

When the program launched, Cigna described it as the first GLP-1 management program with a financial guarantee for health plans. The program caps yearly cost increases for plan sponsors at 15%.

EncircleRx controls costs through a combination of prior authorizations...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Insurance, Payer
Physicians say prior authorization stands in the way of medically necessary care
Insurers closed out 2024 on shaky footing
Automating Insurance Verification: A Game-Changer for Pre-Visit Payment Collection
AI-Driven Prior Authorization Denials Raise Concerns Among Physicians, AMA Survey Reveals
STAT+: UnitedHealth buyouts, and drug pricing spreads

Share This Article